Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 1/2018

09.01.2017 | Original Article

Paraoxonase 1 (PON1) gene polymorphism and haplotype analysis in type 2 diabetes mellitus: a case–control study in the south Iranian population

verfasst von: Elham Moasser, Negar Azarpira, Ali Ghorbani dalini, Babak Shirazi

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Paraoxonase-1 (PON1) is involved in prevention of lipid peroxidation and has been associated with diseases characterized by high oxidative stress, such as cardiovascular disease and diabetes. It has been studied as a potential candidate gene for diabetes risk, but direct evidence from genetic association studies remains inconclusive. We performed an analysis in order to investigate the association between three PON1 polymorphisms (Q192R, L55M, and −108C>T) with type 2 diabetes mellitus (T2DM) in south Iranian population. A total of 340 individuals (171 documented T2DM patients and 169 healthy controls) were examined in this study. After DNA isolation and PCR-RFLP, the products were analyzed for L55M and Q192R polymorphisms in coding region and for −108C>T in promotor sequence of PON1. Statistical analysis showed that all genotypes of Q192R and −108C>T polymorphisms were not associated with diabetes (P > 0.05). However, in PON1 55 gene polymorphism, the allelic frequency of methionine (M) was significantly higher in T2DM patients compared to controls (37 vs. 28%, P < 0.05). In addition, a strong association was found between the LM+MM group and diabetes (P = 0.006). The results of the haplotype analysis for the combinations of the three polymorphisms in patients were shown that the haplotype L-T-R frequency was significantly lower in patients as compared to the controls with odds ratio of 0.28 (OR = 0.28, 95% CI 0.13–0.60, P = 0.0004). The most frequent haplotype in two patient and control groups was L-C-Q (31 and 30.2%, respectively). Met allele of PON1 55 gene polymorphism is an independent risk factor for T2DM and the L-T-R may represent as a protective haplotype in south Iranian population. Our results showed that the frequencies of polymorphisms of PON1 in the south Iranian population differ to some of those observed in other ethnic groups and provide useful data for epidemiological studies.
Literatur
1.
Zurück zum Zitat World Health Organization. Diabetes mellitus fact sheet no. 312. Geneva: WHO; 2006. World Health Organization. Diabetes mellitus fact sheet no. 312. Geneva: WHO; 2006.
2.
Zurück zum Zitat Powers AC. Diabetes mellitus. In: Braud E (ed) Harrison’s principles of internal medicine, 16th edn. McGraw Hill Medical Publishing Division; 2005. Powers AC. Diabetes mellitus. In: Braud E (ed) Harrison’s principles of internal medicine, 16th edn. McGraw Hill Medical Publishing Division; 2005.
3.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.CrossRefPubMed Whiting DR, Guariguata L, Weil C. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.CrossRefPubMed
4.
Zurück zum Zitat Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Promot Heal. 2002;122:28–34.CrossRef Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Promot Heal. 2002;122:28–34.CrossRef
5.
Zurück zum Zitat Friedlyand LE, Philipson LH. Oxidative reactive species in cell injury: mechanism in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci. 2006;1066:136–51.CrossRef Friedlyand LE, Philipson LH. Oxidative reactive species in cell injury: mechanism in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci. 2006;1066:136–51.CrossRef
7.
Zurück zum Zitat Robertson RP, Harmon J, Tran PO. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003;52:581–7.CrossRefPubMed Robertson RP, Harmon J, Tran PO. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003;52:581–7.CrossRefPubMed
8.
Zurück zum Zitat Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys. 2005;43:289–330.CrossRefPubMed Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys. 2005;43:289–330.CrossRefPubMed
9.
Zurück zum Zitat Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009;1;46(2):83–106.CrossRef Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009;1;46(2):83–106.CrossRef
10.
Zurück zum Zitat Tomás M, Latorre G, Sentí M, Marrugat J. The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis. Rev Esp Cardiol. 2004;57(6):557–69.CrossRefPubMed Tomás M, Latorre G, Sentí M, Marrugat J. The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis. Rev Esp Cardiol. 2004;57(6):557–69.CrossRefPubMed
11.
Zurück zum Zitat Kinumi T, Ogawa Y, Kimata J, Saito Y, Yoshida Y, Niki E. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic Res. 2005;39(12):1335–44.CrossRefPubMed Kinumi T, Ogawa Y, Kimata J, Saito Y, Yoshida Y, Niki E. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic Res. 2005;39(12):1335–44.CrossRefPubMed
12.
Zurück zum Zitat Mackness MI, Durrington PN, Mackness B. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs. 2004;4(4):211–7.CrossRefPubMed Mackness MI, Durrington PN, Mackness B. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs. 2004;4(4):211–7.CrossRefPubMed
13.
Zurück zum Zitat Karabina SA, Lehner AN, Frank E, Parthasarathy S, Santanam N. Oxidative inactivation of paraoxonase-implications in diabetes mellitus and atherosclerosis. Biochim Biophys Acta. 2005;1725(2):213–21.CrossRefPubMed Karabina SA, Lehner AN, Frank E, Parthasarathy S, Santanam N. Oxidative inactivation of paraoxonase-implications in diabetes mellitus and atherosclerosis. Biochim Biophys Acta. 2005;1725(2):213–21.CrossRefPubMed
14.
Zurück zum Zitat Kim DS, Marsillach J, Furlong CE, Jarvik GP. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics. 2013;14(12):1495–515.CrossRefPubMedPubMedCentral Kim DS, Marsillach J, Furlong CE, Jarvik GP. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics. 2013;14(12):1495–515.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Liu YL, Yang J, Zheng J, Liu DW, Liu T, Wang JM, et al. Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson’s disease: a HuGE review and meta-analysis. Gene. 2012;15;501(2):188–92.CrossRef Liu YL, Yang J, Zheng J, Liu DW, Liu T, Wang JM, et al. Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson’s disease: a HuGE review and meta-analysis. Gene. 2012;15;501(2):188–92.CrossRef
16.
Zurück zum Zitat Xie S, Li J, Chen Y, Wang C, Zhang H, Mo D. Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene. Mol Biol Rep. 2010;37(3):1347–53.CrossRefPubMed Xie S, Li J, Chen Y, Wang C, Zhang H, Mo D. Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene. Mol Biol Rep. 2010;37(3):1347–53.CrossRefPubMed
17.
Zurück zum Zitat Gross ER, La Disa Jr JF, Weihrauch D, Olson LE, Kress TT, Hettrick DA, et al. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol. 2003;284(5):H1552–9.CrossRefPubMed Gross ER, La Disa Jr JF, Weihrauch D, Olson LE, Kress TT, Hettrick DA, et al. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol. 2003;284(5):H1552–9.CrossRefPubMed
18.
Zurück zum Zitat Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res. 2005;579(1–2):37–46.CrossRefPubMed Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res. 2005;579(1–2):37–46.CrossRefPubMed
19.
Zurück zum Zitat Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.CrossRefPubMed Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.CrossRefPubMed
20.
Zurück zum Zitat Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedeberg's Arch Pharmacol. 2004;369(1):78–88.CrossRef Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedeberg's Arch Pharmacol. 2004;369(1):78–88.CrossRef
21.
Zurück zum Zitat Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol. 2005;70(11):1673–84.CrossRefPubMed Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol. 2005;70(11):1673–84.CrossRefPubMed
22.
Zurück zum Zitat Ceron JJ, Tecles F, Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update. BMC Veterinary Res. 2014;10:74. Ceron JJ, Tecles F, Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update. BMC Veterinary Res. 2014;10:74.
23.
Zurück zum Zitat Furlong CE, Richter RJ, Li WF, Brophy VH, Carlson C, Rieder M, et al. The functional consequences of polymorphisms in the human PON1 gene. InThe paraoxonases: their role in disease development and xenobiotic metabolism. Netherlands: Springer; 2008. Furlong CE, Richter RJ, Li WF, Brophy VH, Carlson C, Rieder M, et al. The functional consequences of polymorphisms in the human PON1 gene. InThe paraoxonases: their role in disease development and xenobiotic metabolism. Netherlands: Springer; 2008.
24.
25.
Zurück zum Zitat Mackness B, Mackness M, Aviram M, Paragh G. The paraoxonases: their role in disease development and xenobiotic metabolism. Springer Science & Business Media; 2007. Mackness B, Mackness M, Aviram M, Paragh G. The paraoxonases: their role in disease development and xenobiotic metabolism. Springer Science & Business Media; 2007.
26.
Zurück zum Zitat Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation. 2000;101(21):2510–7.CrossRefPubMed Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation. 2000;101(21):2510–7.CrossRefPubMed
27.
Zurück zum Zitat Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics. 2001;11(1):77–84.CrossRefPubMed Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics. 2001;11(1):77–84.CrossRefPubMed
28.
Zurück zum Zitat Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol. 2000;20(2):516–21.CrossRefPubMed Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol. 2000;20(2):516–21.CrossRefPubMed
29.
Zurück zum Zitat Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol. 2004;61(3):351–6.CrossRefPubMed Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol. 2004;61(3):351–6.CrossRefPubMed
30.
Zurück zum Zitat James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes. 2000;49(8):1390–3.CrossRefPubMed James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes. 2000;49(8):1390–3.CrossRefPubMed
31.
Zurück zum Zitat Grdic M, Barisic K, Rumora L. Genetic frequencies of paraoxonase 1 gene polymorphisms in Croatian population. Croat Chem Acta. 2008;81:105–11. Grdic M, Barisic K, Rumora L. Genetic frequencies of paraoxonase 1 gene polymorphisms in Croatian population. Croat Chem Acta. 2008;81:105–11.
32.
Zurück zum Zitat Moasser E, Azarpira N, Shirazi B, Saadat M, Geramizadeh B. Genetic polymorphisms of glutathione-s-transferase M1 and T1 genes with risk of diabetic retinopathy in Iranian population. Iran J Basic Med Sci. 2014;17(5):351–6.PubMedPubMedCentral Moasser E, Azarpira N, Shirazi B, Saadat M, Geramizadeh B. Genetic polymorphisms of glutathione-s-transferase M1 and T1 genes with risk of diabetic retinopathy in Iranian population. Iran J Basic Med Sci. 2014;17(5):351–6.PubMedPubMedCentral
33.
Zurück zum Zitat Moasser E, Kazemi-Nezhad SR, Saadat M, Azarpira N. Study of the association between glutathione S-transferase (GSTM1, GSTT1, GSTP1) polymorphisms with type II diabetes mellitus in southern of Iran. Mol Biol Rep. 2012;39(12):10187–92.CrossRefPubMed Moasser E, Kazemi-Nezhad SR, Saadat M, Azarpira N. Study of the association between glutathione S-transferase (GSTM1, GSTT1, GSTP1) polymorphisms with type II diabetes mellitus in southern of Iran. Mol Biol Rep. 2012;39(12):10187–92.CrossRefPubMed
34.
Zurück zum Zitat Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA. 2008;299(11):1265–76.CrossRefPubMed Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA. 2008;299(11):1265–76.CrossRefPubMed
35.
Zurück zum Zitat Kordi-Tamandani DM, Hashemi M, Sharifi N, Kaykhaei MA, Torkamanzehi A. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol Biol Rep. 2012;39(2):937–43.CrossRefPubMed Kordi-Tamandani DM, Hashemi M, Sharifi N, Kaykhaei MA, Torkamanzehi A. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol Biol Rep. 2012;39(2):937–43.CrossRefPubMed
36.
Zurück zum Zitat Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis. 1998;4;139(2):341–9.CrossRef Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis. 1998;4;139(2):341–9.CrossRef
37.
Zurück zum Zitat Agachan B, Yilmaz H, Karaali Z, Isbir T. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem Funct. 2004;22:163–8.CrossRefPubMed Agachan B, Yilmaz H, Karaali Z, Isbir T. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem Funct. 2004;22:163–8.CrossRefPubMed
38.
Zurück zum Zitat Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, et al. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a north-west Indian population. Gene. 2011;487(1):88–95.CrossRefPubMed Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, et al. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a north-west Indian population. Gene. 2011;487(1):88–95.CrossRefPubMed
39.
Zurück zum Zitat Flekac M, Skrha J, Zídková K, Lacinová Z, Hilgertová J. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus. Physiol Res. 2008;57(5):717–26.PubMed Flekac M, Skrha J, Zídková K, Lacinová Z, Hilgertová J. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus. Physiol Res. 2008;57(5):717–26.PubMed
40.
Zurück zum Zitat Prokopenko I, McCarthy MI, Lindgren CM Type 2 diabetes: new genes, new understanding Trends Gene 2008 24 (12): 613–621 Prokopenko I, McCarthy MI, Lindgren CM Type 2 diabetes: new genes, new understanding Trends Gene 2008 24 (12): 613–621
Metadaten
Titel
Paraoxonase 1 (PON1) gene polymorphism and haplotype analysis in type 2 diabetes mellitus: a case–control study in the south Iranian population
verfasst von
Elham Moasser
Negar Azarpira
Ali Ghorbani dalini
Babak Shirazi
Publikationsdatum
09.01.2017
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 1/2018
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-016-0544-z

Weitere Artikel der Ausgabe 1/2018

International Journal of Diabetes in Developing Countries 1/2018 Zur Ausgabe

Position Statement

Diabetes and travel